AMORPHOUS SPARSENTAN COMPOSITIONS
An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders. Una forma amorfa de un compuesto que tiene la estructura (I), (ver Fórmula) o una sal farmacéuticamente acep...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WU Xiangming MACIKENAS Dainius HULVAT James Francis RUBY Kale |
| description | An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.
Una forma amorfa de un compuesto que tiene la estructura (I), (ver Fórmula) o una sal farmacéuticamente aceptable del mismo. Esos compuestos pueden usarse para el tratamiento de enfermedades o trastornos renales. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2021007258A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2021007258A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2021007258A3</originalsourceid><addsrcrecordid>eNrjZFB09PUPCvDwDw1WCA5wDAp29Qtx9FNw9vcN8A_2DPH09wvmYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBkaGBgbmRqYWjsZEKQIAkUIjLA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AMORPHOUS SPARSENTAN COMPOSITIONS</title><source>esp@cenet</source><creator>WU Xiangming ; MACIKENAS Dainius ; HULVAT James Francis ; RUBY Kale</creator><creatorcontrib>WU Xiangming ; MACIKENAS Dainius ; HULVAT James Francis ; RUBY Kale</creatorcontrib><description>An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.
Una forma amorfa de un compuesto que tiene la estructura (I), (ver Fórmula) o una sal farmacéuticamente aceptable del mismo. Esos compuestos pueden usarse para el tratamiento de enfermedades o trastornos renales.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210816&DB=EPODOC&CC=MX&NR=2021007258A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210816&DB=EPODOC&CC=MX&NR=2021007258A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WU Xiangming</creatorcontrib><creatorcontrib>MACIKENAS Dainius</creatorcontrib><creatorcontrib>HULVAT James Francis</creatorcontrib><creatorcontrib>RUBY Kale</creatorcontrib><title>AMORPHOUS SPARSENTAN COMPOSITIONS</title><description>An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.
Una forma amorfa de un compuesto que tiene la estructura (I), (ver Fórmula) o una sal farmacéuticamente aceptable del mismo. Esos compuestos pueden usarse para el tratamiento de enfermedades o trastornos renales.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB09PUPCvDwDw1WCA5wDAp29Qtx9FNw9vcN8A_2DPH09wvmYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBkaGBgbmRqYWjsZEKQIAkUIjLA</recordid><startdate>20210816</startdate><enddate>20210816</enddate><creator>WU Xiangming</creator><creator>MACIKENAS Dainius</creator><creator>HULVAT James Francis</creator><creator>RUBY Kale</creator><scope>EVB</scope></search><sort><creationdate>20210816</creationdate><title>AMORPHOUS SPARSENTAN COMPOSITIONS</title><author>WU Xiangming ; MACIKENAS Dainius ; HULVAT James Francis ; RUBY Kale</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2021007258A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WU Xiangming</creatorcontrib><creatorcontrib>MACIKENAS Dainius</creatorcontrib><creatorcontrib>HULVAT James Francis</creatorcontrib><creatorcontrib>RUBY Kale</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WU Xiangming</au><au>MACIKENAS Dainius</au><au>HULVAT James Francis</au><au>RUBY Kale</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AMORPHOUS SPARSENTAN COMPOSITIONS</title><date>2021-08-16</date><risdate>2021</risdate><abstract>An amorphous form of a compound having structure (I), or a pharmaceutically acceptable salt thereof, is provided. Such compounds may be used for the treatment of kidney diseases or disorders.
Una forma amorfa de un compuesto que tiene la estructura (I), (ver Fórmula) o una sal farmacéuticamente aceptable del mismo. Esos compuestos pueden usarse para el tratamiento de enfermedades o trastornos renales.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; spa |
| recordid | cdi_epo_espacenet_MX2021007258A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | AMORPHOUS SPARSENTAN COMPOSITIONS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T18%3A37%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WU%20Xiangming&rft.date=2021-08-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2021007258A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |